EU to give accelerated approval to variant-modified coronavirus vaccines: Reports
A vaccine improved by the manufacturer on the basis of the previous vaccine to combat new mutations no longer has to go through…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
University of Oxford to assess COVID-19 vaccine response among children for first time
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17
Study reveals how coronavirus could hijack human cells
These findings may lead to the development of new drugs for treating COVID-19
COVID-19 mRNA vaccines can face uptake issues over disinformation and safety concerns: GlobalData
Experts estimate that achieving herd immunity to COVID-19 will required upwards of 70–90 per cent of the population to have…
PNB Vesper completes Phase 2 of clinical trials of GPP-Baladol on COVID-19 patients
Clinical trial report to be submitted to Drug Controller General of India on February 22, 2021
COVID-19 vaccines worth Rs 338 crores exported from India so far: Piyush Goyal
The exports include grant of the vaccine doses to friendly countries and commercial shipments.
COVID-19 vaccine from AstraZeneca/Oxford may see more global uptake due to good efficacy: GlobalData
GlobalData expects that the low cost of the AstraZeneca/Oxford vaccine will allow it to be used in low-income countries – where…
US buys additional 100 million doses COVID-19 vaccine from Moderna
Total of 300 million doses ordered by the US government to date, the company has supplied over 41 million doses so far
Celltrion develops neutralising antibody cocktail to tackle COVID-19 variant spread
CT-P59 demonstrated neutralising capability against key emerging mutations, including the UK variant in addition to six variant…
Reason for COVID-19 cases downturn in India is unclear: GlobalData
In India, the current rate of new cases is 10 per one million population, in marked contrast to the US, where the rate is 370 new…
WHO recommends AstraZeneca COVID-19 vaccine for widespread use
South Africa this week paused its rollout of the AstraZeneca vaccine after data from a small trial showed it did not protect…
India will endeavour to meet Canada’s vaccine needs, Modi tells Trudeau
India, with several vaccine manufacturing facilities, is fast emerging as a key supplier of shots to the world
UK government extends contract with Wockhardt to fill-finish COVID-19 vaccines
This expands the original agreement from 18 to 24 months i.e., until August 2022 and the manufacturing will continue to be…
J&J to bring COVID-19 vaccine to India in partnership with Biological E
Biological E has said it can produce 600 million doses for J&J and more than one billion doses a year of its own vaccine,…
AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19
Lilly plans to manufacture more than 250,000 doses of the bamlanivimab and etesevimab therapy throughout Q1 2021, and up to a…
India says it has no concerns about efficacy of AstraZeneca vaccine
South Africa delayed use of the vaccine after researchers found it offered minimal protection against mild-to-moderate COVID-19…
India orders 14.5 mn more COVID-19 vaccine doses from SII and Bharat Biotech
It has ordered 10 million more doses from the Serum Institute of India and 4.5 million from Bharat Biotech
Vaccine trials essential to evaluate effectiveness against new COVID-19 variants: GlobalData
The largest proportion of the ongoing vaccine trials are now in Phase II (38.6 per cent) and Phase III (36.3 per cent), after…
India set to meet world’s 70 per cent COVID-19 vaccine needs: Amit Shah
He also said that 55 lakh people in the country have been given COVID-19 vaccine in the last 21 days and the Centre is working to…
UK says COVID-19 booster and annual vaccinations very probable
A COVID-19 booster in the autumn and then annual vaccinations are very probable, Britain's vaccine deployment minister said on…